Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Heliyon|September 10, 2024
Development of deep learning model for diagnosing muscle-invasive bladder cancer on MRI with vision transformerYasuhisa Kurata, Mizuho Nishio, Yusaku Moribata, et al.
International Journal of Clinical Oncology|August 20, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in JapanToshiki Anami, Takanobu Motoshima, Yuto Matsushita, et al.
Japanese Journal of Clinical Oncology|January 9, 2026
Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative studyKimihiko Masui, Naoki Hayata, Toshinari Yamasaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2026
Younger Age Is Associated With Early Urinary Continence Recovery After Robot-Assisted Radical ProstatectomyHiroki Hagimoto, Masashi Kubota, Kei Mizuno, et al.
World Journal of Urology|September 26, 2024
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapyKazutoshi Fujita, Yuto Matsushita, Shingo Toyoda, et al.
Cancer Immunology, Immunotherapy : CII|July 8, 2021
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLRTakashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, et al.
International Journal of Clinical Oncology|July 16, 2026
Sex differences in the prognostic value of body mass index after curative nephrectomy for high-risk renal cell carcinoma: a multicenter cohort studyShigeki Koterazawa, Takayuki Sumiyoshi, Noboru Shibasaki, et al.
Clinical Genitourinary Cancer|May 7, 2024
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world DataRyotaro Tomida, Masayuki Takahashi, Yuto Matsushita, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]Toru Kanno, Takahiro Inoue, Katsuhiro Ito, et al.
Journal of Geriatric Oncology|July 9, 2021
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matchingNaotaka Nishiyama, Takashi Kobayashi, Shintaro Narita, et al.
Pageof 7